Assessing Clinical Severity and Prognosis in Adolescents With Anorexia Nervosa and Atypical Anorexia Nervosa Using the Albumin‐Globulin Ratio
European Eating Disorders Review · 2026-09 · 34 (5) · 1193-1208
DOI: 10.1002/erv.70106 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Eating Disorders Review, online erschienen am 04.04.2026. Verfasst von Eylem Şerife Kalkan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Adolescent Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye. Hauptthemen laut MEDLINE: Anorexia Nervosa, Serum Albumin, Serum Globulins. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The albumin‐globulin ratio (AGR) is a biochemical marker reflecting nutritional and inflammatory status, with significant prognostic value in chronic conditions. This study examined its association with clinical/biochemical markers in adolescents with anorexia nervosa (AN) and atypical AN (AAN).
Method
This retrospective study analysed data from 294 adolescents (103 AN, 191 AAN) aged 12–18 years, presented at an adolescent medicine clinic between 2016 and 2023. AGR values were calculated and relationship between AGR and markers of both disease severity (rate of weight loss, vital sign instability, amenorrhoea, hospitalisation need) and prognosis (rehospitalisation, menstrual recovery, achievement of target body weight) was evaluated. An ideal AGR cut‐off of 1.84 was identified using receiver operating characteristic curve analysis.
Results
Mean AGR was higher in AN than AAN (1.85 ± 0.28 vs. 1.73 ± 0.31, p < 0.001). AGR correlated negatively with body mass index z ‐score, blood pressure, and heart rate. AGR ≥ 1.84 was associated with amenorrhoea, hospitalisation need at admission, hypotension, bradycardia, hypothermia, and leucopenia. Higher AGR predicted rehospitalisation during follow‐up and longer menstrual resumption duration.
Conclusion
Unlike other chronic conditions, a higher AGR at presentation was associated with both greater medical disease severity and poorer prognosis in adolescents with AN and AAN, possibly due to relatively preserved albumin alongside decreased globulin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Adolescent Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
- Department of Statistics, Hacettepe University, Ankara, Türkiye.
ORCID-Profile: Eylem Şerife Kalkan, Ayşe Bilge Baklaci, Yelda Kiliç, Sinem Akgül, Nilgün Özgül, Melis Pehlivanturk Kizilkan
Zitieren
APA
Kalkan, E. Ş., Baklaci, A. B., Kiliç, Y., Akgül, S., Özgül, N., & Pehlivanturk Kizilkan, M. (2026). Assessing Clinical Severity and Prognosis in Adolescents With Anorexia Nervosa and Atypical Anorexia Nervosa Using the Albumin‐Globulin Ratio. European Eating Disorders Review, 34(5), 1193-1208. https://doi.org/10.1002/erv.70106
Vancouver
Kalkan EŞ, Baklaci AB, Kiliç Y, Akgül S, Özgül N, Pehlivanturk Kizilkan M. Assessing Clinical Severity and Prognosis in Adolescents With Anorexia Nervosa and Atypical Anorexia Nervosa Using the Albumin‐Globulin Ratio. European Eating Disorders Review. 2026;34(5):1193-1208. doi:10.1002/erv.70106
BibTeX
@article{Kalkan2026,
author = {Kalkan, Eylem Şerife and Baklaci, Ayşe Bilge and Kiliç, Yelda and Akgül, Sinem and Özgül, Nilgün and Pehlivanturk Kizilkan, Melis},
title = {Assessing Clinical Severity and Prognosis in Adolescents With Anorexia Nervosa and Atypical Anorexia Nervosa Using the Albumin‐Globulin Ratio},
journal = {European Eating Disorders Review},
year = {2026},
volume = {34},
number = {5},
pages = {1193--1208},
doi = {10.1002/erv.70106}
}
EUVIMED